What is the most recent earnings date for CAMP stock?
CAMP4 THERAPEUTICS CORP (CAMP) last reported earnings on 3/5/2026.
NASDAQ:CAMP • US13463J1016
Past quarterly earnings results for CAMP4 THERAPEUTICS CORP (CAMP), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.86 | -0.31 | -177.96% | 69.61% | 348K | 472.597K | -26.36% | -46.63% |
| Q3 2025 | -0.55 | -0.49 | -12.73% | 97.73% | 795K | 530.4K | 49.89% | - |
| Q2 2025 | -0.62 | -0.69 | 9.55% | -169.57% | 1.497M | 612K | 144.61% | -97.57% |
| Q1 2025 | -0.62 | -0.71 | 13.17% | -369.57% | 858K | 25.5K | 3,264.71% | -98.79% |
| Q4 2024 | -2.83 | -0.84 | -237.33% | -305.07% | 652K | 147.9K | 340.84% | -99.17% |
| Q3 2024 | -24.19 | -1.09 | -2,111.25% | - | 339.997K | -100.00% | -100.00% | |
| Q2 2024 | -0.23 | 0.70 | -132.68% | -1,050.00% | 61.714M | 71.758M | -14.00% | -15.26% |
| Q1 2024 | 0.23 | 0.94 | -75.49% | 330.00% | 70.891M | 77.173M | -8.14% | 9.52% |
| Q4 2023 | 1.38 | 0.38 | 263.11% | 13,900.00% | 78.506M | 80.22M | -2.14% | 14.81% |
| Q3 2023 | 0.00 | 0.00 | -100.00% | 100.00% | 78.889M | 76.799M | 2.72% | 14.70% |
| Q2 2023 | -0.02 | -0.03 | 30.79% | -125.00% | 72.828M | 70.658M | 3.07% | -7.83% |
| Q1 2023 | -0.10 | -0.03 | -209.56% | -225.00% | 64.726M | 70.818M | -8.60% | -18.76% |
| Q4 2022 | -0.01 | -0.08 | 87.35% | -107.14% | 68.377M | 69.801M | -2.04% | 20.33% |
| Q3 2022 | -0.08 | 0.08 | -194.50% | -214.29% | 68.777M | 80.763M | -14.84% | -12.40% |
| Q2 2022 | 0.08 | 0.06 | 27.18% | 366.67% | 79.011M | 81.509M | -3.06% | 6.20% |
| Q1 2022 | 0.08 | 0.07 | 12.04% | 300.00% | 79.674M | 81.859M | -2.67% | 8.06% |
| Q4 2021 | 0.14 | 0.06 | 152.82% | 366.67% | 56.823M | 85.352M | -33.43% | 32.55% |
| Q3 2021 | 0.07 | 0.02 | 220.24% | -53.33% | 78.512M | 84.635M | -7.23% | -18.72% |
| Q2 2021 | -0.03 | 0.00 | -1,956.77% | -121.43% | 74.397M | 78.379M | -5.08% | -20.21% |
| Q1 2021 | 0.02 | -0.06 | 136.12% | -83.33% | 73.731M | 76.8M | -4.00% | -17.22% |
| Q4 2020 | 0.03 | 0.03 | 18.31% | - | 42.87M | 87.66M | -51.10% | - |
| Q3 2020 | 0.15 | 0.15 | -1.23% | - | 96.597M | 97.014M | -0.43% | - |
| Q2 2020 | 0.14 | 0.12 | 19.01% | - | 93.236M | 93.385M | -0.16% | - |
| Q1 2020 | 0.12 | 0.09 | 34.02% | - | 89.07M | 88.646M | 0.48% | - |
Notes
CAMP4 THERAPEUTICS CORP (CAMP) last reported earnings on 3/5/2026.
CAMP4 THERAPEUTICS CORP (CAMP) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, CAMP4 THERAPEUTICS CORP (CAMP) has beaten EPS estimates in 2 out of 4 releases.